Clinical Trial Update: Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update reporting safety, pharmacokinetics, and preliminary anti-tumor activity of intravenous TKM-080301 in adults with advanced hepato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TKM-080301

Snippet

Sponsor: Arbutus Biopharma Corporation | Conditions: Hepatocellular Carcinoma, Hepatoma | Phase 1, Phase 2 | Status: COMPLETED